Back to catalog
Tesamorelin 5 MG
Metabolic research

Tesamorelin5 MG

Prepared for controlled laboratory study of endocrine and metabolic-signaling models.

MaterialSynthetic peptide analogue
SpecificationPurity 99%+
Research contextEndocrine-signaling research.
Veyvanta / profile

Compound profile

* Vial labels may use shortened names to keep the label legible. The full material and composition are stated in this profile.

Material

Synthetic peptide analogue

Composition

Single peptide material.

Research context

Endocrine-signaling research.

Research interest

Why it draws attention

Tesamorelin draws attention for its defined GHRH-pathway activity and the human research connecting that axis with GH, IGF-1, and visceral-adipose endpoints.

Signals researchers are following

  • 01

    Growth-hormone-releasing hormone and IGF-1 signaling

  • 02

    Visceral adipose tissue and ectopic-fat endpoints

Evidence levelHuman clinical evidence
These themes describe areas of scientific and community interest. They are not established outcomes or recommendations for use.
Published evidence / research profile

What the published research shows

A source-led view of the findings reported to date, the maturity of the evidence, and the limits that matter when interpreting it.

Evidence levelHuman clinical evidence

Common research directions

  • Growth-hormone-releasing hormone and IGF-1 signaling
  • Visceral adipose tissue and ectopic-fat endpoints

Reported findings

Randomized trials in people with HIV-associated abdominal fat accumulation reported reductions in visceral adipose tissue. Effects were population-specific, and visceral fat reaccumulated after treatment was discontinued in extension data.

How to read the evidence

This is comparatively mature human evidence for a narrow clinical context. It should not be generalized to routine weight loss, other populations, or uncharacterized research material.

This summary describes published research on the named material or its components. It does not establish safety, efficacy, equivalence, or suitability of this Veyvanta research product for human use.

Lab math

Reconstitution & measurement calculator

Convert a declared vial amount and diluent volume into nominal concentration, liquid volume, and the equivalent position on a U-100 scale.

Open full calculator
Research product
Research productTesamorelin / 5 MG
Calculation basisTesamorelin
Target unit
Calculated measurement

Enter a positive diluent volume and target amount to calculate.

A calculation, not a protocol

This tool performs unit conversion only. It does not recommend an amount, frequency, route, diluent, handling method, or human use. Results assume ideal mixing and a U-100 scale of 100 units per mL; validated laboratory procedures and material-specific compatibility take priority.

Vial verification

Verify this vial

This is the evergreen product profile. Enter the code from a physical vial to display its specific record.

Verify this vial
Tesamorelin verification QR code

Vial verification QR

This QR code opens the current product profile with its associated vial record.

WhatsApp